跳至主要内容
临床试验/ACTRN12621000557831
ACTRN12621000557831招募中4 期

A randomised controlled trial of dexmedetomidine compared to placebo to reduce pain after spinal fusion surgery

The Royal Melbourne Hospital0 个研究点目标入组 128 人开始时间: 2021年5月12日最近更新:
适应症

试验速览

阶段
4 期
状态
招募中
入组人数
128

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Treatment
盲法
Blinded (masking used)

入排标准

年龄范围
18 Years 至 o limit(—)
性别
All

入选标准

  • Adults 18 years and older having thoracic and/or lumbar spinal fusion surgery using a posterior approach.
  • Anticipated to stay at least one post-operative night in hospital.

排除标准

  • Unable or unwilling to provide consent or unable to communicate numerical rating scale pain score, including cognitively impaired, planned to remain on mechanical ventilation post-operatively or non-English speaking patients.
  • Known diagnosis of significant cardiac conduction disease (second- or third-degree heart block, sick sinus syndrome, atrial fibrillation and atrial flutter) unless a pacemaker is present.
  • Known diagnosis of severe ischemic heart disease, valvular heart disease or cardiomyopathy
  • Known diagnosis of liver cirrhosis
  • Bradycardia (heart rate (HR) < 50 bpm) in theatre suite before surgery
  • Hypotension (systolic blood pressure (SBP) < 100 mmHg) in theatre suite before surgery
  • Known diagnosis of allergy or hypersensitivity reactions to dexmedetomidine or any of the protocolised anaesthetic drugs.
  • Previously enrolled into the SPADE study.

研究者

相似试验